Diabetes Drug MDL Ruling Helps Branded Cos. In Label Fights
A California federal court's decision for drugmakers in multidistrict litigation over their alleged failure to warn of their Type 2 diabetes drugs' potential to cause pancreas problems is among the first...To view the full article, register now.
Already a subscriber? Click here to view full article